首页 > 最新文献

Swiss medical weekly最新文献

英文 中文
Treating Menière's disease with rimegepant.
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-20 DOI: 10.57187/s.4147
Stefan C A Hegemann, Angela Schell

A recent hypothesis states that Menière's disease is caused by inappropriate expression, i.e. enhanced release of the neurotransmitter calcitonin gene-related peptide. Here, we tested this hypothesis by administering rimegepant, a new calcitonin gene-related peptide antagonist approved for the acute treatment of migraine and for the prevention of episodic migraine, to six patients with both Menière's disease and migraine. Two patients received the first dose of 75 mg rimegepant to treat an acute attack of Menière's disease. One of these two plus the remaining four patients were treated with 75 mg rimegepant every other day for secondary prevention. One patient developed an allergic reaction after the first administration and was excluded from further treatment. In the two patients treated during acute Menière's disease, symptoms were relieved and resolved about 30 min earlier than migraine symptoms. While all five patients had reduced migraine, all completely resolved Menière's symptoms on preventive therapy with rimegepant for up to eight months. These results support the idea that calcitonin gene-related peptide is linked to the pathogenesis of Menière's disease and suggest that inhibition of calcitonin gene-related peptide signalling may represent a promising therapeutic option for Menière's disease patients.

{"title":"Treating Menière's disease with rimegepant.","authors":"Stefan C A Hegemann, Angela Schell","doi":"10.57187/s.4147","DOIUrl":"https://doi.org/10.57187/s.4147","url":null,"abstract":"<p><p>A recent hypothesis states that Menière's disease is caused by inappropriate expression, i.e. enhanced release of the neurotransmitter calcitonin gene-related peptide. Here, we tested this hypothesis by administering rimegepant, a new calcitonin gene-related peptide antagonist approved for the acute treatment of migraine and for the prevention of episodic migraine, to six patients with both Menière's disease and migraine. Two patients received the first dose of 75 mg rimegepant to treat an acute attack of Menière's disease. One of these two plus the remaining four patients were treated with 75 mg rimegepant every other day for secondary prevention. One patient developed an allergic reaction after the first administration and was excluded from further treatment. In the two patients treated during acute Menière's disease, symptoms were relieved and resolved about 30 min earlier than migraine symptoms. While all five patients had reduced migraine, all completely resolved Menière's symptoms on preventive therapy with rimegepant for up to eight months. These results support the idea that calcitonin gene-related peptide is linked to the pathogenesis of Menière's disease and suggest that inhibition of calcitonin gene-related peptide signalling may represent a promising therapeutic option for Menière's disease patients.</p>","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"4147"},"PeriodicalIF":2.1,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143469092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The key role of base rates: systematic review and meta-analysis of the predictive value of four risk assessment instruments.
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-14 DOI: 10.57187/s.3517
Michael A Weber, Nina Schnyder, Madeleine A Kirschstein, Marc Graf, Jérôme Endrass, Astrid Rossegger
<p><strong>Aims of the study: </strong>Many countries have seen a decline in recidivism rates over the past decades. These base rates are pertinent information for assessing the recidivism risk of offenders. They provide a foundation for clinical assessment and an empirical basis for risk assessment instrument norms, which inform expected recidivism rates. The present study explored the extent to which base rates influence the validity of risk assessment instruments.</p><p><strong>Methods: </strong>We systematically reviewed the available evidence on the discrimination ability of four well-established risk assessment instruments used to estimate the probability of recidivism for general (Level of Service Inventory-Revised [LSI-R]), violent (Violence Risk Appraisal Guide [VRAG]), sexual (Static-99R), and intimate partner violent offences (Ontario Domestic Assault Risk Assessment [ODARA]). We conducted a bivariate logit-normal random effects meta-analysis of sensitivity and false positive rates and modelled the positive and negative predictive values. We used base rates as reported in (a) the construction samples of each risk assessment instrument and (b) recent official statistics and peer-reviewed articles for different offence categories and countries. To assess the risk of bias, we used the Joanna Briggs Institute Critical Appraisal Checklist for Diagnostic Test Accuracy Studies.</p><p><strong>Results: </strong>We screened 644 studies and subsequently analysed 102, of which 96 were included in the systematic review and 24 in the meta-analyses. Discrimination was comparable for all four instruments (median area under the curve = 0.68-0.71). The information needed to calculate summary statistics of sensitivity and false positive rate was often not reported, and a risk of bias may be present in up to half of the studies. The largest summary sensitivity and false positive rate were estimated for the ODARA, followed by the LSI-R, the VRAG, and the Static-99R. If base rates are low, positive predictive values tend to be relatively low, while negative predictive values are higher: positive predictive value = 0.032-0.133 and negative predictive value = 0.985-0.989 for sexual offences; positive predictive value = 188-0.281 and negative predictive value = 0.884-0.964 for intimate partner violence; positive predictive value = 0.218-0.241 and negative predictive value = 0.907-0.942 for violent offences; positive predictive value = 0.335-0.377 and negative predictive value = 0.809-0.810 for general offences.</p><p><strong>Conclusions: </strong>When interpreting the results of individual risk assessments, it is not sufficient to provide the discrimination of the instrument; the risk statement must also address the positive predictive value and discuss its implications for the specific case. As recidivism rates are neither stable over time nor uniform across countries or samples, the primary interpretation of risk assessment instruments should rely on the per
{"title":"The key role of base rates: systematic review and meta-analysis of the predictive value of four risk assessment instruments.","authors":"Michael A Weber, Nina Schnyder, Madeleine A Kirschstein, Marc Graf, Jérôme Endrass, Astrid Rossegger","doi":"10.57187/s.3517","DOIUrl":"https://doi.org/10.57187/s.3517","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Aims of the study: &lt;/strong&gt;Many countries have seen a decline in recidivism rates over the past decades. These base rates are pertinent information for assessing the recidivism risk of offenders. They provide a foundation for clinical assessment and an empirical basis for risk assessment instrument norms, which inform expected recidivism rates. The present study explored the extent to which base rates influence the validity of risk assessment instruments.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We systematically reviewed the available evidence on the discrimination ability of four well-established risk assessment instruments used to estimate the probability of recidivism for general (Level of Service Inventory-Revised [LSI-R]), violent (Violence Risk Appraisal Guide [VRAG]), sexual (Static-99R), and intimate partner violent offences (Ontario Domestic Assault Risk Assessment [ODARA]). We conducted a bivariate logit-normal random effects meta-analysis of sensitivity and false positive rates and modelled the positive and negative predictive values. We used base rates as reported in (a) the construction samples of each risk assessment instrument and (b) recent official statistics and peer-reviewed articles for different offence categories and countries. To assess the risk of bias, we used the Joanna Briggs Institute Critical Appraisal Checklist for Diagnostic Test Accuracy Studies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We screened 644 studies and subsequently analysed 102, of which 96 were included in the systematic review and 24 in the meta-analyses. Discrimination was comparable for all four instruments (median area under the curve = 0.68-0.71). The information needed to calculate summary statistics of sensitivity and false positive rate was often not reported, and a risk of bias may be present in up to half of the studies. The largest summary sensitivity and false positive rate were estimated for the ODARA, followed by the LSI-R, the VRAG, and the Static-99R. If base rates are low, positive predictive values tend to be relatively low, while negative predictive values are higher: positive predictive value = 0.032-0.133 and negative predictive value = 0.985-0.989 for sexual offences; positive predictive value = 188-0.281 and negative predictive value = 0.884-0.964 for intimate partner violence; positive predictive value = 0.218-0.241 and negative predictive value = 0.907-0.942 for violent offences; positive predictive value = 0.335-0.377 and negative predictive value = 0.809-0.810 for general offences.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;When interpreting the results of individual risk assessments, it is not sufficient to provide the discrimination of the instrument; the risk statement must also address the positive predictive value and discuss its implications for the specific case. As recidivism rates are neither stable over time nor uniform across countries or samples, the primary interpretation of risk assessment instruments should rely on the per","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"3517"},"PeriodicalIF":2.1,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143469144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leveraging free-text diagnoses to identify patients with diabetes mellitus, obesity or dyslipidaemia - a cross-sectional study in a large Swiss primary care database. 利用自由文本诊断识别糖尿病、肥胖症或血脂异常患者--一项在瑞士大型初级保健数据库中进行的横断面研究。
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-13 DOI: 10.57187/s.3360
Donika Balaj, Jakob M Burgstaller, Audrey Wallnöfer, Katja Weiss, Oliver Senn, Thomas Rosemann, Thomas Grischott, Stefan Markun

Background: Electronic medical records (EMRs) in general practice provide various methods for identifying patients with specific diagnoses. While several studies have focused on case identification via structured EMR components, diagnoses in general practice are frequently documented as unstructured free-text entries, making their use for research challenging. Furthermore, diagnoses may remain undocumented even when evidence of the underlying disease exists within structured EMR data.

Objective: This study aimed to quantify the extent to which free-text diagnoses contribute to identifying additional cases of diabetes mellitus, obesity and dyslipidaemia (target diseases) and assess the cases missed when relying exclusively on free-text entries.

Methods: This cross-sectional study utilised EMR data from all consultations up to 2019 for 6,000 patients across 10 general practices in Switzerland. Diagnoses documented in a free-text entry field for diagnoses were manually coded for target diseases. Cases were defined as patients with a corresponding coded free-text diagnosis or meeting predefined criteria in structured EMR components (medication data or clinical and laboratory parameters). For each target disease, prevalence was calculated along with the proportion of cases identified exclusively via free-text diagnoses and the proportion missed when using free-text diagnoses alone.

Results: The prevalence estimates for diabetes mellitus, obesity and dyslipidaemia were 8.8%, 16.2% and 38.9%, respectively. Few cases relied exclusively on free-text diagnoses for identification, but a substantial proportion of cases were missed when relying solely on free-text diagnoses, particularly for obesity (19.5% exclusively identified; 50.7% missed) and dyslipidaemia (8.7% exclusively identified; 53.3% missed).

Conclusion: Free-text diagnoses were of limited utility for case identification of diabetes mellitus, obesity or dyslipidaemia, suggesting that manual coding of free-text diagnoses may not always be justified. Relying solely on free-text diagnoses for case identification is not recommended, as substantial proportions of cases may remain undetected, leading to biased prevalence estimates.

{"title":"Leveraging free-text diagnoses to identify patients with diabetes mellitus, obesity or dyslipidaemia - a cross-sectional study in a large Swiss primary care database.","authors":"Donika Balaj, Jakob M Burgstaller, Audrey Wallnöfer, Katja Weiss, Oliver Senn, Thomas Rosemann, Thomas Grischott, Stefan Markun","doi":"10.57187/s.3360","DOIUrl":"https://doi.org/10.57187/s.3360","url":null,"abstract":"<p><strong>Background: </strong>Electronic medical records (EMRs) in general practice provide various methods for identifying patients with specific diagnoses. While several studies have focused on case identification via structured EMR components, diagnoses in general practice are frequently documented as unstructured free-text entries, making their use for research challenging. Furthermore, diagnoses may remain undocumented even when evidence of the underlying disease exists within structured EMR data.</p><p><strong>Objective: </strong>This study aimed to quantify the extent to which free-text diagnoses contribute to identifying additional cases of diabetes mellitus, obesity and dyslipidaemia (target diseases) and assess the cases missed when relying exclusively on free-text entries.</p><p><strong>Methods: </strong>This cross-sectional study utilised EMR data from all consultations up to 2019 for 6,000 patients across 10 general practices in Switzerland. Diagnoses documented in a free-text entry field for diagnoses were manually coded for target diseases. Cases were defined as patients with a corresponding coded free-text diagnosis or meeting predefined criteria in structured EMR components (medication data or clinical and laboratory parameters). For each target disease, prevalence was calculated along with the proportion of cases identified exclusively via free-text diagnoses and the proportion missed when using free-text diagnoses alone.</p><p><strong>Results: </strong>The prevalence estimates for diabetes mellitus, obesity and dyslipidaemia were 8.8%, 16.2% and 38.9%, respectively. Few cases relied exclusively on free-text diagnoses for identification, but a substantial proportion of cases were missed when relying solely on free-text diagnoses, particularly for obesity (19.5% exclusively identified; 50.7% missed) and dyslipidaemia (8.7% exclusively identified; 53.3% missed).</p><p><strong>Conclusion: </strong>Free-text diagnoses were of limited utility for case identification of diabetes mellitus, obesity or dyslipidaemia, suggesting that manual coding of free-text diagnoses may not always be justified. Relying solely on free-text diagnoses for case identification is not recommended, as substantial proportions of cases may remain undetected, leading to biased prevalence estimates.</p>","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"3360"},"PeriodicalIF":2.1,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143469129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacillus cereus endocarditis: a case-based literature review. 蜡样芽孢杆菌心内膜炎:基于病例的文献综述。
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-12 DOI: 10.57187/s.4015
Selina Ehrenzeller, Karin Züger, Lisa Oberli, Roberto Buonomano

Bacillus cereus, a gram-positive, rod-shaped bacterium known for both its environmental resilience and its pathogenic potential, has been increasingly recognised as a serious health threat outside the traditional contexts of food poisoning. This narrative review, anchored by a detailed case study, highlights the pathogen's role in rare but severe infections like endocarditis, especially among intravenous drug users, who are particularly vulnerable, among other identified risk factors. The case of a 62-year-old female with a history of intravenous cocaine use who developed Bacillus cereus endocarditis underscores the complexities of diagnosing and managing such infections. Despite the challenges posed by the patient's adverse reactions to vancomycin, the mainstay treatment, successful management was achieved through persistent administration adjusted for tolerance and side effects. This review meticulously compiles all known cases of Bacillus cereus endocarditis from the past decades, beginning with the first identified case fifty years ago in 1974. It provides a thorough analysis, identifying various risk factors and outlining the evolution of treatment protocols. This comprehensive approach not only enhances understanding of the pathogen's clinical impact but also clarifies the progression of therapeutic strategies, highlighting the individual adaptations necessary to address this challenging infection effectively.

蜡样芽孢杆菌(Bacillus cereus)是一种革兰氏阳性杆状细菌,以其对环境的适应能力和潜在的致病性而闻名。这篇叙述性综述以一个详细的病例研究为基础,强调了这种病原体在心内膜炎等罕见但严重的感染中的作用,尤其是在静脉注射吸毒者中,他们特别容易受到感染。一位 62 岁的女性患者有静脉注射可卡因的历史,她患上了蜡样芽孢杆菌心内膜炎,这个病例凸显了诊断和处理此类感染的复杂性。尽管患者对万古霉素(主要治疗药物)的不良反应带来了挑战,但通过持续用药并根据耐受性和副作用进行调整,最终成功控制了病情。这篇综述从五十年前 1974 年发现的第一例病例开始,精心整理了过去几十年中所有已知的蜡样芽孢杆菌心内膜炎病例。它提供了详尽的分析,确定了各种风险因素,并概述了治疗方案的演变。这种全面的方法不仅加深了对病原体临床影响的了解,还阐明了治疗策略的进展,突出了有效解决这种具有挑战性的感染所需的个体适应性。
{"title":"Bacillus cereus endocarditis: a case-based literature review.","authors":"Selina Ehrenzeller, Karin Züger, Lisa Oberli, Roberto Buonomano","doi":"10.57187/s.4015","DOIUrl":"https://doi.org/10.57187/s.4015","url":null,"abstract":"<p><p>Bacillus cereus, a gram-positive, rod-shaped bacterium known for both its environmental resilience and its pathogenic potential, has been increasingly recognised as a serious health threat outside the traditional contexts of food poisoning. This narrative review, anchored by a detailed case study, highlights the pathogen's role in rare but severe infections like endocarditis, especially among intravenous drug users, who are particularly vulnerable, among other identified risk factors. The case of a 62-year-old female with a history of intravenous cocaine use who developed Bacillus cereus endocarditis underscores the complexities of diagnosing and managing such infections. Despite the challenges posed by the patient's adverse reactions to vancomycin, the mainstay treatment, successful management was achieved through persistent administration adjusted for tolerance and side effects. This review meticulously compiles all known cases of Bacillus cereus endocarditis from the past decades, beginning with the first identified case fifty years ago in 1974. It provides a thorough analysis, identifying various risk factors and outlining the evolution of treatment protocols. This comprehensive approach not only enhances understanding of the pathogen's clinical impact but also clarifies the progression of therapeutic strategies, highlighting the individual adaptations necessary to address this challenging infection effectively.</p>","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"4015"},"PeriodicalIF":2.1,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143415363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishing educational entry to practice requirements for advanced practice nursing in Switzerland: current debate and nursing perspective.
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-12 DOI: 10.57187/s.4301
Jessica Gaylord, Janette Ribaut, Jenny Gentizon, Sara Colomer-Lahiguera, Laurence Robatto, Cédric Mabire, Franziska Zúñiga, Manuela Eicher

No abstract available.

{"title":"Establishing educational entry to practice requirements for advanced practice nursing in Switzerland: current debate and nursing perspective.","authors":"Jessica Gaylord, Janette Ribaut, Jenny Gentizon, Sara Colomer-Lahiguera, Laurence Robatto, Cédric Mabire, Franziska Zúñiga, Manuela Eicher","doi":"10.57187/s.4301","DOIUrl":"https://doi.org/10.57187/s.4301","url":null,"abstract":"<p><p>No abstract available.</p>","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"4301"},"PeriodicalIF":2.1,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143442024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study.
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-06 DOI: 10.57187/s.4225
Raphael Magnolini, Kuvinda Kossinna, Daniel Bjasch, Muriel Kruijver, Philip Bruggmann, Oliver Senn
<p><strong>Background: </strong>The non-medical use of anabolic androgenic steroids for the improvement of aesthetic and sports performance purposes has become a global substance use disorder, particularly among men in recreational sports. Health outcomes among people who are using anabolic androgenic steroids may be detrimental, yet healthcare services for these users are scarce. Therefore, the aim of this project was to conduct a quality assurance study to evaluate the feasibility of providing current best clinical practice for anabolic androgenic steroids users based on the published literature within a primary care practice in Zurich (Switzerland).</p><p><strong>Methods: </strong>A primary healthcare practice for current or past anabolic androgenic steroids use was established at the Arud Centre for Addiction Medicine in Zurich providing specialised medical care for this population. The reporting and methodology to evaluate feasibility of this quality assurance study follow a checklist for pilot studies. The primary feasibility outcomes for this study were satisfaction with the services received (customer satisfaction score), as well as loyalty towards the services (net promoter score). These customer metrics have been used successfully in the medical field to measure patient experiences, as well as infer future word-of-mouth advertisement (i.e. return and refer). Furthermore, the objective was to describe patient characteristics and substance use behaviours in a Swiss context. Patients could access these services in Zurich from 1 June 2023 onwards. The recruitment strategy was word-of-mouth advertising among anabolic androgenic steroids users and paper advertisement (i.e. flyers) about the healthcare service. Eligibility criteria were based on legal restrictions regarding doping laws and professional ethical principles of medicine. In an initial visit at the practice, a focused patient history was assessed, and patients received a physical, psychometric, instrumental as well as laboratory examination. Datasets are summarised using descriptive statistics.</p><p><strong>Results: </strong>Overall, 34 eligible patients were seen over the period from June until December 2023. Excellent results regarding loyalty towards the service (net promoter score: 100; integer) as well as patient satisfaction with the received services (customer satisfaction score: 100%) were achieved. Patients were commonly young professional males (mean: 38.5 years, standard deviation: 8 years), with educational level beyond compulsory schooling. The main motivation for using anabolic androgenic steroids was aesthetic purposes. Acquisition of these substances occurred mostly through non-medical sources. Patterns of anabolic androgenic steroids use were complex with extensive polypharmacy and concomitant illicit substance use. Most patients suffered from side effects with multiple physical as well as mental health complications. Many abnormal findings were found regarding th
背景:非医疗使用合成代谢雄性类固醇来改善美观和运动表现,已成为一种全球性的药物使用障碍,尤其是在休闲运动的男性中。使用合成代谢雄性类固醇的人的健康状况可能会受到损害,但针对这些使用者的医疗保健服务却很少。因此,本项目旨在开展一项质量保证研究,以评估在苏黎世(瑞士)的一家初级保健诊所内根据已发表的文献为合成代谢雄性类固醇使用者提供当前最佳临床实践的可行性:方法:苏黎世阿鲁德成瘾医学中心针对目前或过去使用合成代谢雄性类固醇的人群设立了初级保健实践,为其提供专门的医疗服务。这项质量保证研究的报告和可行性评估方法遵循试点研究的核对表。这项研究的主要可行性结果是对所接受服务的满意度(客户满意度评分)以及对服务的忠诚度(净促进者评分)。这些客户指标已成功应用于医疗领域,以衡量患者体验,并推断未来的口碑广告(即回访和推荐)。此外,我们的目标是在瑞士的背景下描述患者的特征和药物使用行为。患者可从 2023 年 6 月 1 日起在苏黎世获得这些服务。招募策略是在合成代谢雄性类固醇使用者中进行口碑宣传,并通过纸质广告(即传单)介绍医疗保健服务。资格标准基于兴奋剂法的法律限制和医学职业道德原则。在初次就诊时,会对患者病史进行重点评估,并对患者进行体格、心理、仪器和实验室检查。数据集采用描述性统计进行总结:从 6 月到 2023 年 12 月,共有 34 名符合条件的患者接受了治疗。患者对服务的忠诚度(净促进者得分:100;整数)以及对所接受服务的满意度(客户满意度得分:100%)均达到了极高的水平。患者通常是年轻的职业男性(平均年龄:38.5 岁,标准差:8 岁),教育程度超过义务教育水平。使用合成代谢雄性类固醇的主要动机是为了美观。这些药物主要通过非医疗渠道获得。合成代谢雄性类固醇的使用模式非常复杂,包括广泛的多种药物和同时使用非法药物。大多数患者都有副作用,并伴有多种身体和精神健康并发症。在体格检查、实验室检查和仪器检查中发现了许多异常情况,虽然大多是轻微和短暂的,但有些可能对健康造成严重影响:通过这项首次质量保证研究,我们证明,在瑞士的初级保健实践中,针对休闲运动中合成代谢雄性类固醇使用者整合当前最佳临床实践似乎是可行的,而且接受度很高。此外,这些患者可能会有高风险行为,而且合并症的发病率也很高。合成代谢雄性类固醇使用者可能会从初级医疗机构提供和协调的综合医疗保健中受益。在初步研究结果的基础上,这些服务将在更大范围内继续开展,以进一步评估和降低这一使用人群的健康风险。重要的是,目前的兴奋剂立法被证明是为这一使用人群提供适当医疗服务的主要限制因素,因此,要避免这一日益严重的公共健康威胁,立法改革至关重要。
{"title":"Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study.","authors":"Raphael Magnolini, Kuvinda Kossinna, Daniel Bjasch, Muriel Kruijver, Philip Bruggmann, Oliver Senn","doi":"10.57187/s.4225","DOIUrl":"https://doi.org/10.57187/s.4225","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The non-medical use of anabolic androgenic steroids for the improvement of aesthetic and sports performance purposes has become a global substance use disorder, particularly among men in recreational sports. Health outcomes among people who are using anabolic androgenic steroids may be detrimental, yet healthcare services for these users are scarce. Therefore, the aim of this project was to conduct a quality assurance study to evaluate the feasibility of providing current best clinical practice for anabolic androgenic steroids users based on the published literature within a primary care practice in Zurich (Switzerland).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A primary healthcare practice for current or past anabolic androgenic steroids use was established at the Arud Centre for Addiction Medicine in Zurich providing specialised medical care for this population. The reporting and methodology to evaluate feasibility of this quality assurance study follow a checklist for pilot studies. The primary feasibility outcomes for this study were satisfaction with the services received (customer satisfaction score), as well as loyalty towards the services (net promoter score). These customer metrics have been used successfully in the medical field to measure patient experiences, as well as infer future word-of-mouth advertisement (i.e. return and refer). Furthermore, the objective was to describe patient characteristics and substance use behaviours in a Swiss context. Patients could access these services in Zurich from 1 June 2023 onwards. The recruitment strategy was word-of-mouth advertising among anabolic androgenic steroids users and paper advertisement (i.e. flyers) about the healthcare service. Eligibility criteria were based on legal restrictions regarding doping laws and professional ethical principles of medicine. In an initial visit at the practice, a focused patient history was assessed, and patients received a physical, psychometric, instrumental as well as laboratory examination. Datasets are summarised using descriptive statistics.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Overall, 34 eligible patients were seen over the period from June until December 2023. Excellent results regarding loyalty towards the service (net promoter score: 100; integer) as well as patient satisfaction with the received services (customer satisfaction score: 100%) were achieved. Patients were commonly young professional males (mean: 38.5 years, standard deviation: 8 years), with educational level beyond compulsory schooling. The main motivation for using anabolic androgenic steroids was aesthetic purposes. Acquisition of these substances occurred mostly through non-medical sources. Patterns of anabolic androgenic steroids use were complex with extensive polypharmacy and concomitant illicit substance use. Most patients suffered from side effects with multiple physical as well as mental health complications. Many abnormal findings were found regarding th","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"4225"},"PeriodicalIF":2.1,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143469034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare needs, expectations and experiences of people experiencing homelessness in Western Switzerland: a qualitative and quantitative descriptive study.
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-04 DOI: 10.57187/s.3659
Luana Schaad, Evelyne Hangartner, Chantal Berna, Justin Nikles, Laurent Hyvert, Tshahé Anonga Varela, David Campbell, Olivier Hugli, Susan E Collins, Caroline Leblanc, Christine Loignon, Patrick Bodenmann, Véronique S Grazioli

Aims: The literature from Canada, the UK and the USA reports health inequities among people experiencing homelessness; however little is known about this population's health in Switzerland. Our study is the first to comprehensively assess health needs, expectations and experiences of people experiencing homelessness in Switzerland.

Methods: We describe the health needs, expectations and experiences of people experiencing homelessness in French-speaking Switzerland, using both quantitative and qualitative methods. From May to August 2022, 123 people experiencing homelessness completed quantitative questionnaires about health needs, expectations and experiences. Recruitment took place in 10 homeless-serving institutions across four cities in the Canton of Vaud. A total of 18 people experiencing homelessness and 13 professionals involved in the homeless-serving sector completed qualitative interviews. For the qualitative strand, we selected people experiencing homelessness using quota sampling based on health insurance, residency status and sex representativeness according to the study population. For homeless-serving sector professionals, we used quota sampling by professions (i.e. night watcher in shelters; social/healthcare workers) ensuring balance. In addition, we aimed to recruit at least one homeless-serving sector professional from each of the ten institutions included in the parent research project.

Results: The most common health issues reported were musculoskeletal, dental and psychiatric. Thirty-one percent of people experiencing homelessness had visited emergency rooms and 27% a community health centre in the prior 6 months. People experiencing homelessness reported low quality of life according to the WHOQOL, especially in social and environmental domains; 33% reported moderate and 17% high grade of psychological distress. Findings indicated that up to 32% of participants reported facing difficulties in reaching out to the healthcare system. In qualitative interviews, people experiencing homelessness described positive perceptions about the Swiss healthcare system. However, people experiencing homelessness reported various barriers encountered while seeking healthcare (e.g., health insurance, financial barriers, appointment delays, hesitancy in accessing care, prioritising other needs). Both groups commonly reported that social situations impacted the health and healthcare use of people experiencing homelessness.

Conclusion: People experiencing homelessness in Switzerland are not spared by the common health inequities reported in Canada, the USA and the UK. Our results provide interesting foundations on which to build public health actions towards health equity for people experiencing homelessness in Switzerland and suggest that they could benefit from additional medical follow-up and tailored interventions.

{"title":"Healthcare needs, expectations and experiences of people experiencing homelessness in Western Switzerland: a qualitative and quantitative descriptive study.","authors":"Luana Schaad, Evelyne Hangartner, Chantal Berna, Justin Nikles, Laurent Hyvert, Tshahé Anonga Varela, David Campbell, Olivier Hugli, Susan E Collins, Caroline Leblanc, Christine Loignon, Patrick Bodenmann, Véronique S Grazioli","doi":"10.57187/s.3659","DOIUrl":"https://doi.org/10.57187/s.3659","url":null,"abstract":"<p><strong>Aims: </strong>The literature from Canada, the UK and the USA reports health inequities among people experiencing homelessness; however little is known about this population's health in Switzerland. Our study is the first to comprehensively assess health needs, expectations and experiences of people experiencing homelessness in Switzerland.</p><p><strong>Methods: </strong>We describe the health needs, expectations and experiences of people experiencing homelessness in French-speaking Switzerland, using both quantitative and qualitative methods. From May to August 2022, 123 people experiencing homelessness completed quantitative questionnaires about health needs, expectations and experiences. Recruitment took place in 10 homeless-serving institutions across four cities in the Canton of Vaud. A total of 18 people experiencing homelessness and 13 professionals involved in the homeless-serving sector completed qualitative interviews. For the qualitative strand, we selected people experiencing homelessness using quota sampling based on health insurance, residency status and sex representativeness according to the study population. For homeless-serving sector professionals, we used quota sampling by professions (i.e. night watcher in shelters; social/healthcare workers) ensuring balance. In addition, we aimed to recruit at least one homeless-serving sector professional from each of the ten institutions included in the parent research project.</p><p><strong>Results: </strong>The most common health issues reported were musculoskeletal, dental and psychiatric. Thirty-one percent of people experiencing homelessness had visited emergency rooms and 27% a community health centre in the prior 6 months. People experiencing homelessness reported low quality of life according to the WHOQOL, especially in social and environmental domains; 33% reported moderate and 17% high grade of psychological distress. Findings indicated that up to 32% of participants reported facing difficulties in reaching out to the healthcare system. In qualitative interviews, people experiencing homelessness described positive perceptions about the Swiss healthcare system. However, people experiencing homelessness reported various barriers encountered while seeking healthcare (e.g., health insurance, financial barriers, appointment delays, hesitancy in accessing care, prioritising other needs). Both groups commonly reported that social situations impacted the health and healthcare use of people experiencing homelessness.</p><p><strong>Conclusion: </strong>People experiencing homelessness in Switzerland are not spared by the common health inequities reported in Canada, the USA and the UK. Our results provide interesting foundations on which to build public health actions towards health equity for people experiencing homelessness in Switzerland and suggest that they could benefit from additional medical follow-up and tailored interventions.</p>","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"3659"},"PeriodicalIF":2.1,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143442079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alveolar echinococcosis in the canton of Geneva between 2010 and 2021: a descriptive analysis.
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-04 DOI: 10.57187/s.3863
Manon Ollagnon, Solange Bresson-Hadni, Laurent Spahr, Laura Rubbia-Brandt, Christian Toso, François Chappuis

Background: Alveolar echinococcosis is a rare but potentially severe parasitic disease caused by the larval stage of Echinococcus multilocularis, endemic in many countries in the northern hemisphere, including Switzerland. While the liver is most commonly affected, other organs can also be involved either by contiguity or haematogenous spread. To date, there is no epidemiological or clinical data on alveolar echinococcosis in the canton of Geneva.

Objectives: To describe the demographic, epidemiological, clinical and therapeutic characteristics of alveolar echinococcosis in the canton of Geneva between 2010 and 2021.

Methods: An investigation was conducted among physicians from Geneva University Hospitals (HUG) and the private sector likely to encounter patients diagnosed with alveolar echinococcosis between 2010 and 2021. All patients being treated in the canton of Geneva were included. After obtaining their consent, an epidemiological questionnaire was completed by patients, and a clinical questionnaire by their referring physicians. Demographic, epidemiological and clinical data were entered into REDCap, then extracted and analysed.

Results: Of a total of 27 patients diagnosed with alveolar echinococcosis, 25 were included in the study; one patient did not provide his consent and one patient could not be contacted. The annual incidence of alveolar echinococcosis in the canton of Geneva was calculated at 0.24 cases per 100,000 inhabitants based on the subset (n = 14) domiciled in Geneva. The vast majority of patients (n = 24; 96%) were followed at HUG. The median age of patients was 55 years (range: 17-79) with a slight predominance of women (56%). Reported risk factors for alveolar echinococcosis included owning a vegetable garden (70.8%), often unfenced, practicing composting (69.6%), and owning a dog (58.3%) or a cat (58.3%). Four patients (16%) had an immunosuppressive condition. Only 52% of patients were symptomatic at the time of diagnosis. The liver was affected in most cases (n = 24; 96%), but one patient had a primary splenic location. Surgical resection for curative purposes was performed in 13 patients (52%). All patients received parasitostatic treatment with albendazole, discontinued in 5 patients (20%) due to drug-induced hepatitis. Three patients died (12%), of which two directly related to alveolar echinococcosis.

Conclusion: Alveolar echinococcosis, a rare but severe disease, is endemic in the canton of Geneva. The establishment of mandatory reporting of this disease in Switzerland would allow monitoring of its epidemiological evolution. Primary and secondary prevention measures, currently non-existent, could potentially lower the incidence and severity of the disease.

{"title":"Alveolar echinococcosis in the canton of Geneva between 2010 and 2021: a descriptive analysis.","authors":"Manon Ollagnon, Solange Bresson-Hadni, Laurent Spahr, Laura Rubbia-Brandt, Christian Toso, François Chappuis","doi":"10.57187/s.3863","DOIUrl":"https://doi.org/10.57187/s.3863","url":null,"abstract":"<p><strong>Background: </strong>Alveolar echinococcosis is a rare but potentially severe parasitic disease caused by the larval stage of Echinococcus multilocularis, endemic in many countries in the northern hemisphere, including Switzerland. While the liver is most commonly affected, other organs can also be involved either by contiguity or haematogenous spread. To date, there is no epidemiological or clinical data on alveolar echinococcosis in the canton of Geneva.</p><p><strong>Objectives: </strong>To describe the demographic, epidemiological, clinical and therapeutic characteristics of alveolar echinococcosis in the canton of Geneva between 2010 and 2021.</p><p><strong>Methods: </strong>An investigation was conducted among physicians from Geneva University Hospitals (HUG) and the private sector likely to encounter patients diagnosed with alveolar echinococcosis between 2010 and 2021. All patients being treated in the canton of Geneva were included. After obtaining their consent, an epidemiological questionnaire was completed by patients, and a clinical questionnaire by their referring physicians. Demographic, epidemiological and clinical data were entered into REDCap, then extracted and analysed.</p><p><strong>Results: </strong>Of a total of 27 patients diagnosed with alveolar echinococcosis, 25 were included in the study; one patient did not provide his consent and one patient could not be contacted. The annual incidence of alveolar echinococcosis in the canton of Geneva was calculated at 0.24 cases per 100,000 inhabitants based on the subset (n = 14) domiciled in Geneva. The vast majority of patients (n = 24; 96%) were followed at HUG. The median age of patients was 55 years (range: 17-79) with a slight predominance of women (56%). Reported risk factors for alveolar echinococcosis included owning a vegetable garden (70.8%), often unfenced, practicing composting (69.6%), and owning a dog (58.3%) or a cat (58.3%). Four patients (16%) had an immunosuppressive condition. Only 52% of patients were symptomatic at the time of diagnosis. The liver was affected in most cases (n = 24; 96%), but one patient had a primary splenic location. Surgical resection for curative purposes was performed in 13 patients (52%). All patients received parasitostatic treatment with albendazole, discontinued in 5 patients (20%) due to drug-induced hepatitis. Three patients died (12%), of which two directly related to alveolar echinococcosis.</p><p><strong>Conclusion: </strong>Alveolar echinococcosis, a rare but severe disease, is endemic in the canton of Geneva. The establishment of mandatory reporting of this disease in Switzerland would allow monitoring of its epidemiological evolution. Primary and secondary prevention measures, currently non-existent, could potentially lower the incidence and severity of the disease.</p>","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"3863"},"PeriodicalIF":2.1,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143469033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of a multimodal intervention on junior and senior hospital physicians' job satisfaction and wellbeing: a matched pre- and post-intervention study.
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-04 DOI: 10.57187/s.3801
Monica Levy, Jacques Donzé, Hervé Zender, Gregor John

Background: Physician wellbeing has a direct impact on patient care. Meta-analyses have concluded that interventions are moderately effective at reducing physician burnout, but new studies are needed to target populations at higher risk (e.g. young physicians) and determine which interventions might be most effective.   METHOD: Using matched questionnaires, we conducted a cross-sectional pre-post study of a multimodal intervention to promote physician wellbeing. The intervention involved a change in institutional culture, information on occupational wellbeing, and the organisation of undisturbed lunch breaks and short breaks during the day. The primary outcome was the proportion of physicians satisfied with their job (scoring >3 points  on the Work-Related Quality of Life [WRQoL] scale). Secondary outcomes were overall WRQoL score, WRQoL subscale scores, number of short breaks taken during the working day, number of lunch breaks taken, physicians' likeliness of recommending their job to peers, monthly overtime hours worked and monthly sick days. Subgroup analyses included women vs men, residents vs chief residents/senior physicians, and participants with vs without children. We also explored potential factors influencing WRQoL in the pre-intervention population.

Results: Pre- and post-intervention questionnaires were returned by 134 (63%) and 87 (42%) physicians, respectively, with 75 responding to both (matched). The intervention significantly increased the proportion of physicians satisfied with their job (from 49/75 [65%] to 58/75 [77%], p = 0.02), median overall WRQoL score (from 3.3 [IQR: 2.8-3.8] to 3.5 [IQR: 3.1-3.8], p <0.01), median Home-Work Interface subscale score (from 2.7 [IQR: 2.0-3.3] to 3.0 [IQR: 2.3-3.7], p = 0.01) and median General Well-Being subscale score (from 3.4 [IQR: 2.6-4.0] to 3.6 [IQR: 3.0-4.0], p <0.01). Residents showed a greater increase in overall WRQoL median score (from 3.2 [IQR: 2.7-3.6] to 3.5 [IQR: 3.3-3.8]) than chief residents/senior physicians (3.3 [IQR: 2.9-3.9] to 3.4 [IQR: 3.0-3.8], p <0.01 for group difference). No significant differences were seen in other subgroups or secondary outcomes in the matched population. Among the 134 participants in the pre-intervention period, those taking a daily lunch break, sleeping 7 hours or more or self-reporting doing sports activities on weekdays had higher overall WRQoL scores.

Conclusions: This wellbeing intervention increased physicians' WRQoL scores. However, the difference was small and its relevance remains uncertain.

背景:医生的健康状况对病人护理有直接影响。元分析得出结论,干预措施对减少医生职业倦怠有一定效果,但需要针对高风险人群(如年轻医生)进行新的研究,并确定哪些干预措施可能最有效。 方法:我们使用匹配的调查问卷,对促进医生身心健康的多模式干预措施进行了一项横断面前后研究。干预措施包括改变机构文化、提供有关职业健康的信息、组织不受干扰的午休和白天的短暂休息。主要结果是对工作满意的医生比例(在与工作相关的生活质量量表中得分大于 3 分)。次要结果包括 WRQoL 总分、WRQoL 子量表得分、工作日短休次数、午休次数、医生向同行推荐其工作的可能性、每月加班时数和每月病假天数。分组分析包括女性与男性、住院医师与住院总医师/高级医师、有子女与无子女的参与者。我们还探讨了影响干预前人群 WRQoL 的潜在因素:分别有 134 名(63%)和 87 名(42%)医生对干预前和干预后的问卷进行了回复,其中 75 名医生对两份问卷都进行了回复(匹配)。干预措施大大提高了对工作满意的医生比例(从 49/75 [65%] 提高到 58/75 [77%],p = 0.02)和 WRQoL 总分的中位数(从 3.3 [IQR: 2.8-3.8] 提高到 3.5 [IQR: 3.1-3.8],p 结论:干预措施提高了医生的 WRQoL 分值:这项福利干预提高了医生的 WRQoL 分数。然而,差异很小,其相关性仍不确定。
{"title":"Impact of a multimodal intervention on junior and senior hospital physicians' job satisfaction and wellbeing: a matched pre- and post-intervention study.","authors":"Monica Levy, Jacques Donzé, Hervé Zender, Gregor John","doi":"10.57187/s.3801","DOIUrl":"https://doi.org/10.57187/s.3801","url":null,"abstract":"<p><strong>Background: </strong>Physician wellbeing has a direct impact on patient care. Meta-analyses have concluded that interventions are moderately effective at reducing physician burnout, but new studies are needed to target populations at higher risk (e.g. young physicians) and determine which interventions might be most effective.   METHOD: Using matched questionnaires, we conducted a cross-sectional pre-post study of a multimodal intervention to promote physician wellbeing. The intervention involved a change in institutional culture, information on occupational wellbeing, and the organisation of undisturbed lunch breaks and short breaks during the day. The primary outcome was the proportion of physicians satisfied with their job (scoring >3 points  on the Work-Related Quality of Life [WRQoL] scale). Secondary outcomes were overall WRQoL score, WRQoL subscale scores, number of short breaks taken during the working day, number of lunch breaks taken, physicians' likeliness of recommending their job to peers, monthly overtime hours worked and monthly sick days. Subgroup analyses included women vs men, residents vs chief residents/senior physicians, and participants with vs without children. We also explored potential factors influencing WRQoL in the pre-intervention population.</p><p><strong>Results: </strong>Pre- and post-intervention questionnaires were returned by 134 (63%) and 87 (42%) physicians, respectively, with 75 responding to both (matched). The intervention significantly increased the proportion of physicians satisfied with their job (from 49/75 [65%] to 58/75 [77%], p = 0.02), median overall WRQoL score (from 3.3 [IQR: 2.8-3.8] to 3.5 [IQR: 3.1-3.8], p <0.01), median Home-Work Interface subscale score (from 2.7 [IQR: 2.0-3.3] to 3.0 [IQR: 2.3-3.7], p = 0.01) and median General Well-Being subscale score (from 3.4 [IQR: 2.6-4.0] to 3.6 [IQR: 3.0-4.0], p <0.01). Residents showed a greater increase in overall WRQoL median score (from 3.2 [IQR: 2.7-3.6] to 3.5 [IQR: 3.3-3.8]) than chief residents/senior physicians (3.3 [IQR: 2.9-3.9] to 3.4 [IQR: 3.0-3.8], p <0.01 for group difference). No significant differences were seen in other subgroups or secondary outcomes in the matched population. Among the 134 participants in the pre-intervention period, those taking a daily lunch break, sleeping 7 hours or more or self-reporting doing sports activities on weekdays had higher overall WRQoL scores.</p><p><strong>Conclusions: </strong>This wellbeing intervention increased physicians' WRQoL scores. However, the difference was small and its relevance remains uncertain.</p>","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"3801"},"PeriodicalIF":2.1,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143415364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Communication and information exchange between practices and hospitals: a survey among primary care practitioners in central Switzerland.
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-03 DOI: 10.57187/s.3585
Rebecca Tomaschek, Patrick E Beeler, Kristina Grgičević, Lena S Müller, Christoph Merlo, Balthasar L Hug

Background: Digital tools are widely utilised to improve communication and information exchange among healthcare professionals. The cantonal hospital in Lucerne was the first to implement the Epic clinical information system in a German-speaking country, including information access for primary care physicians via an electronic health record portal.

Objectives: This study assessed how primary care physicians perceive the communication with hospitals in the canton of Lucerne, including their preferences for discharge summary contents and experiences and utilisation of a regionally implemented electronic health record portal.

Methods: We performed an online survey among primary care physicians and contacted all 323 primary care physicians enlisted as members of the cantonal medical society in Lucerne, Switzerland.

Results: A total of 109 primary care physicians completed the online survey (34% response rate). Half of the primary care physicians were satisfied with hospital communication. Three-quarters (n = 83) wanted to be informed of patients' emergency hospital admission within 48 hours, but only 30% (n = 33) reported being notified. In discharge summaries, primary care physicians expect information on the diagnosis, medication, therapies, and recommendations for follow-up care. A large portion of primary care physicians deemed the electronic health record portal beneficial for patient management. Most primary care physicians utilise the portal to retrieve patient data, but it is rarely used for patient referrals.

Conclusion: Half of primary care physicians were satisfied with communication with regional hospitals. Primary care physicians reported a lack of timely notifications or reports about emergency admissions, in-hospital deaths, and discharges of their patients. Primary care physicians value the electronic health record portal as a supporting tool for patient management.

{"title":"Communication and information exchange between practices and hospitals: a survey among primary care practitioners in central Switzerland.","authors":"Rebecca Tomaschek, Patrick E Beeler, Kristina Grgičević, Lena S Müller, Christoph Merlo, Balthasar L Hug","doi":"10.57187/s.3585","DOIUrl":"https://doi.org/10.57187/s.3585","url":null,"abstract":"<p><strong>Background: </strong>Digital tools are widely utilised to improve communication and information exchange among healthcare professionals. The cantonal hospital in Lucerne was the first to implement the Epic clinical information system in a German-speaking country, including information access for primary care physicians via an electronic health record portal.</p><p><strong>Objectives: </strong>This study assessed how primary care physicians perceive the communication with hospitals in the canton of Lucerne, including their preferences for discharge summary contents and experiences and utilisation of a regionally implemented electronic health record portal.</p><p><strong>Methods: </strong>We performed an online survey among primary care physicians and contacted all 323 primary care physicians enlisted as members of the cantonal medical society in Lucerne, Switzerland.</p><p><strong>Results: </strong>A total of 109 primary care physicians completed the online survey (34% response rate). Half of the primary care physicians were satisfied with hospital communication. Three-quarters (n = 83) wanted to be informed of patients' emergency hospital admission within 48 hours, but only 30% (n = 33) reported being notified. In discharge summaries, primary care physicians expect information on the diagnosis, medication, therapies, and recommendations for follow-up care. A large portion of primary care physicians deemed the electronic health record portal beneficial for patient management. Most primary care physicians utilise the portal to retrieve patient data, but it is rarely used for patient referrals.</p><p><strong>Conclusion: </strong>Half of primary care physicians were satisfied with communication with regional hospitals. Primary care physicians reported a lack of timely notifications or reports about emergency admissions, in-hospital deaths, and discharges of their patients. Primary care physicians value the electronic health record portal as a supporting tool for patient management.</p>","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"3585"},"PeriodicalIF":2.1,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143410658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Swiss medical weekly
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1